| Literature DB >> 27052731 |
Mi-Jeong Park1, Ren Sheng2, Antonina Silkov3, Da-Jung Jung1, Zhi-Gang Wang2, Yao Xin2, Hyunjin Kim2, Pallavi Thiagarajan-Rosenkranz2, Seohyeon Song1, Youngdae Yoon2, Wonhee Nam1, Ilshin Kim4, Eui Kim1, Dong-Gyu Lee1, Yong Chen2, Indira Singaram2, Li Wang2, Myoung Ho Jang4, Cheol-Sang Hwang5, Barry Honig3, Sungho Ryu5, Justin Lorieau2, You-Me Kim6, Wonhwa Cho7.
Abstract
The Src-homology 2 (SH2) domain is a protein interaction domain that directs myriad phosphotyrosine (pY)-signaling pathways. Genome-wide screening of human SH2 domains reveals that ∼90% of SH2 domains bind plasma membrane lipids and many have high phosphoinositide specificity. They bind lipids using surface cationic patches separate from pY-binding pockets, thus binding lipids and the pY motif independently. The patches form grooves for specific lipid headgroup recognition or flat surfaces for non-specific membrane binding and both types of interaction are important for cellular function and regulation of SH2 domain-containing proteins. Cellular studies with ZAP70 showed that multiple lipids bind its C-terminal SH2 domain in a spatiotemporally specific manner and thereby exert exquisite spatiotemporal control over its protein binding and signaling activities in T cells. Collectively, this study reveals how lipids control SH2 domain-mediated cellular protein-protein interaction networks and suggest a new strategy for therapeutic modulation of pY-signaling pathways.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27052731 PMCID: PMC4826312 DOI: 10.1016/j.molcel.2016.01.027
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970